Action 300294 CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Actions

300294

CNE100001FF1

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
35,37 CNY -0,37 % Graphique intraday de China Resources Boya Bio-pharmaceutical Group Co.,Ltd +2,28 % +5,02 %
27/05 CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD : Morgan Stanley passe à neutre sur le dossier ZM
23/04 China Resources Boya Bio-pharmaceutical Group Co, Ltd présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CR Boya Bio-Pharmaceutical Signs 29.5 Million Yuan Construction Contract for Blood Products Facility
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.
CR Boya Bio-Pharmaceutical's January-September Profit Increases
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits
China Resources Boya's H1 Attributable Profit Jumps 16.9%
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit
China Resources Boya Bio-Pharmaceutical Group Co., Ltd. Proposes Dividend for the Year 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300294
  4. Actualités China Resources Boya Bio-pharmaceutical Group Co.,Ltd
  5. Autres langues